agÕæÈ˹ú¼Ê

  • EN
EN

ÐÅÏ¢ÖÐÐÄ

Information Center

ÆóÒµÒªÎÅ

agÕæÈ˹ú¼ÊÉúÎïĸţ·ÖÖ¦¸Ë¾úÒßÃçÉêÇëÐÂÒ©Éú²ú×¢²á»ñÊÜÀí

Ðû²¼Ê±¼ä2018-04-25  |  µã»÷ÂÊ£º

·ÖÏíµ½£º

      ½ñÈÕÎç¼ä£¬agÕæÈ˹ú¼ÊÉúÎïͨ¸æ³Æ£¬ÓÉÈ«×Ê×Ó¹«Ë¾°²»ÕagÕæÈ˹ú¼ÊÁú¿ÆÂíÉúÎïÖÆÒ©ÓÐÏÞ¹«Ë¾Ñз¢µÄ“ĸţ·ÖÖ¦¸Ë¾úÒßÃç(½áºËѬȾÈËȺÓÃ)”ÒÑÍê³ÉÓÃÓÚÔ¤·À½áºË¸Ë¾úDZ·üѬȾÈËȺ±¬·¢½áºË²¡µÄIIIÆÚÁÙ´²ÊÔÑé²¢»ñµÃ¹ú¼ÒÒ©Æ·¼à¶½ÖÎÀí¾ÖµÄÉú²ú×¢²áÊÜÀí(ÊÜÀíºÅ:CXSS1800010¹ú)¡£
      ¸Ã²úÆ·ÓÚ2012Äê12Ô»ñµÃ×¢²á·ÖÀàΪ“Ô¤·ÀÓÃÉúÎïÖÆÆ·”µÄ“Ò©ÎïÁÙ´²ÊÔÑéÅú¼þ”£¨Åú¼þºÅ2012L02749£©£¬²¢ÓÚ2013Äê10Ô¿ªÕ¹ÁÙ´²ÊÔÑé¡£ÒÑÍê³ÉµÄÁÙ´²ÊÔÑé½á¹û±êÃ÷ÒßÃçÄþ¾²ÐԸߣ»Æä±£»¤Ð§¹ûÁè¼ÝÁËÊÀ½çÎÀÉú×éÖ¯2017ÄêÐû²¼µÄ¡¶WHOÓÅÑ¡µÄ½áºË²¡ÐÂÒßÃç²úÆ·ÌØÐÔ£¨WHO Preferred ProductCharacteristics for New Tuberculosis Vaccines£©¡·Öл®¶¨µÄ±£»¤Á¦ÆÀ¼ÛÖ¸±ê£¬¸ÃÑо¿½á¹ûΪ±¾ÒßÃçÉêÇëÐÂÒ©ÉÏÊÐÌṩÁËÐëÒªÇÒÒªº¦µÄÌõ¼þ¡£
      ±¾ÒßÃç¢óÆÚÁÙ´²ÊÔÑé½á¹ûÈç»ñµÃ¹ú¼ÒÒ©Æ·¼à¶½ÖÎÀí¾ÖÈϿɣ¬²¢Åú×¼¸Ã²úÆ·×÷ΪԤ·ÀÓÃÉúÎïÖÆÆ·Ó¦ÓÃÓÚ½áºËDZ·üѬȾÈËȺԤ·À½áºË²¡£¬±¾ÒßÃç¼´¿ÉÉÏÊÐÏúÊÛ¡£
      ½áºË²¡ÒßÃçÊǹú¼ÊÉÏÒßÃçÑо¿µÄÈȵ㣬ƾ¾Ý2017ÄêÊÀ½çÎÀÉú×éÖ¯µÄ½áºË²¡±¨¸æ£¨¡¶Global Tuberculosis Report 2017¡·£©£¬½ØÖ¹2017Äê7Ô£¬¹ú¼ÊÉÏ´¦ÓÚÔÚÑТñ¡¢¢ò¡¢¢óÆÚ½áºË²¡ÒßÃçÁÙ´²Ñо¿ÖвúÆ·½öÓÐ11¼Ò¡£agÕæÈ˹ú¼ÊÁú¿ÆÂí×ÔÖ÷Ñз¢µÄ“ĸţ·ÖÖ¦¸Ë¾úÒßÃ磨½áºËѬȾÈËȺÓã©”ÊÇÈ«ÇòΨһ½øÈë¢óÆÚÁÙ´²Ñо¿µÄ½áºË²¡ÒßÃç¡£
      ±¾ÒßÃç¢óÆÚÁÙ´²ÊÔÑé°´ÆÚÍê³ÉÑо¿£¬±ê¼Ç×ÅÎÒ¹ú³ÉΪÔÚ¹ú¼ÊÉÏÊ׸öÍê³É½áºËDZ·üѬȾԤ·ÀÓÃÒßÃçÁÙ´²Ñо¿µÄ¹ú¼Ò¡£¸ÃÒßÃçÊÇĿǰΪֹÊÀ½çÉÏΨһÍê³É¢óÆÚÈËÌåÁÙ´²ÊÔÑéµÄ´ËÀà½áºË²¡ÒßÃ磬¸ÃÊÔÑéµÄÍê³É¶Ô½áºË¸Ë¾úDZ·üѬȾÈËȺԤ·À½áºË²¡ÒâÒåÖØ´ó¡£

      À´Ô´£ºÐÂÀËÒ½Ò©ÐÂÎÅ 2018-04-25A-A+

ÍøÕ¾µØÍ¼